Invest Now
Samco Star Rating Ads

Dr Agarwals Eye Hospital Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 5,227 up by 2.24%. The total volume of shares on NSE and BSE combined was 674 shares. Its total combined turnover was Rs 0.35 crores.

Dr Agarwals Eye Hospital Ltd Medium and Long Term Market Action

The stock price of Dr Agarwals Eye Hospital Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Dr Agarwals Eye Hospital Ltd Fundamentals

  • Market Cap (Cr): 2325

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Dr Agarwals Eye Hospital Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Dr Agarwals Eye Hospital Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Dr Agarwals Eye Hospital Ltd

Data not available.

Dr Agarwals Eye Hospital Ltd FAQ's

What is Share Price of Dr Agarwals Eye Hospital Ltd?

What is the Market Cap of Dr Agarwals Eye Hospital Ltd?

What is PE Ratio of Dr Agarwals Eye Hospital Ltd?

What is PB Ratio of Dr Agarwals Eye Hospital Ltd?

What is the CAGR of Dr Agarwals Eye Hospital Ltd?

How to Buy Dr Agarwals Eye Hospital Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 92.78% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • Strong Working Capital Cycle
    The company has a great working capital cycle of 44 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.64. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 55% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(01/12/2024)
Stock Valuation
Dark green line
110
0%
0% People are bullish about Dr Agarwals Eye Hospital Ltd
0%
0 % People are bearish about Dr Agarwals Eye Hospital Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Dr Agarwals Eye Hospital Ltd

0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91